PROGNOSTIC VALUE OF THE IMMEDIATE RESPONSE TO SURFACTANT

被引:13
作者
KUINT, J
REICHMAN, B
NEUMANN, L
SHINWELL, ES
机构
[1] BEN GURION UNIV NEGEV, SOROKA MED CTR, DEPT NEONATOL, BEER SHEVA, ISRAEL
[2] BEN GURION UNIV NEGEV, SOROKA MED CTR, DEPT EPIDEMIOL, BEER SHEVA, ISRAEL
来源
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION | 1994年 / 71卷 / 03期
关键词
D O I
10.1136/fn.71.3.F170
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim-To evaluate the association between the immediate response to surfactant treatment and morbidity and mortality in infants with severe respiratory distress syndrome. Methods-The response to surfactant was defined as the difference in the arterial:alveolar (delta a:A) ratio before and one hour after the first surfactant dose. Measurements were obtained from 253 Israeli infants participating in the multicentre Curosurf 4 trial of surfactant replacement therapy. Results-Delta a:A ratios ranged from -0.115 to 0.8 and were significantly related to both birth weight and gestational age. Among infants weighing 1001-1500 g mortality decreased from 40% among very bad responders to zero among good responders. The incidence of pneumothorax decreased with better response. Logistic regression analysis showed a hierarchy of predictive power for mortality: birth weight or gestational age; immediate response to surfactant; severity of initial disease. Conclusion-The immediate response to surfactant treatment is a significant prognostic indicator for mortality and morbidity.
引用
收藏
页码:F170 / F173
页数:4
相关论文
共 16 条
[1]  
CHARON A, 1989, PEDIATRICS, V83, P348
[2]  
FUJIWARA T, 1980, LANCET, V1, P55
[3]  
FUJIWARA T, 1988, SURFACTANT REPLACEME, P99
[4]   MULTICENTER RANDOMIZED TRIAL COMPARING HIGH AND LOW-DOSE SURFACTANT REGIMENS FOR THE TREATMENT OF RESPIRATORY-DISTRESS SYNDROME (THE CUROSURF-4 TRIAL) [J].
HALLIDAY, HL ;
TARNOWMORDI, WO ;
CORCORAN, JD ;
PATTERSON, CC .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1993, 69 (03) :276-280
[5]   EXOGENOUS HUMAN SURFACTANT FOR TREATMENT OF SEVERE RESPIRATORY-DISTRESS SYNDROME - A RANDOMIZED PROSPECTIVE CLINICAL-TRIAL [J].
HALLMAN, M ;
MERRITT, TA ;
JARVENPAA, AL ;
BOYNTON, B ;
MANNINO, F ;
GLUCK, L ;
MOORE, T ;
EDWARDS, D .
JOURNAL OF PEDIATRICS, 1985, 106 (06) :963-969
[6]  
HALLMAN M, 1988, SURFACTANT REPLACEME, P136
[7]   SURFACTANT THERAPY FAILURE IDENTIFIES INFANTS AT RISK FOR PULMONARY MORTALITY [J].
HAMVAS, A ;
DEVINE, T ;
COLE, FS .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1993, 147 (06) :665-668
[8]  
Hessler J R, 1985, Am J Perinatol, V2, P101, DOI 10.1055/s-2007-999924
[9]   IMPACT OF LUNG SURFACTANT THERAPY ON CHRONIC LUNG-DISEASES IN PREMATURE-INFANTS [J].
HUDAK, BB ;
EGAN, EA .
CLINICS IN PERINATOLOGY, 1992, 19 (03) :591-602
[10]   EFFECTS OF 2 RESCUE DOSES OF A SYNTHETIC SURFACTANT ON MORTALITY-RATE AND SURVIVAL WITHOUT BRONCHOPULMONARY DYSPLASIA IN 700-GRAM TO 1350-GRAM INFANTS WITH RESPIRATORY-DISTRESS SYNDROME [J].
LONG, W ;
THOMPSON, T ;
SUNDELL, H ;
SCHUMACHER, R ;
VOLBERG, F ;
GUTHRIE, R .
JOURNAL OF PEDIATRICS, 1991, 118 (04) :595-605